AMPK mediates energetic stress‐induced liver GDF15

Abstract

Growth differentiating factor‐15 (GDF15) is an emerging target for the treatment of obesity and metabolic disease partly due to its ability to suppress food intake. GDF15 expression and secretion are thought to be regulated by a cellular integrated stress response, which involves endoplasmic reticulum (ER) stress. AMPK is another cellular stress sensor, but the relationship between AMPK, ER stress, and GDF15 has not been assessed in vivo. Wildtype (WT), AMPK β1 deficient (AMPKβ1−/−), and CHOP−/− mice were treated with three distinct AMPK activators; AICAR, which is converted to ZMP mimicking the effects of AMP on the AMPKγ isoform, R419, which indirectly activates AMPK through inhibition of mitochondrial respiration, or A769662, a direct AMPK activator which binds the AMPKβ1 isoform ADaM site causing allosteric activation. Following treatments, liver Gdf15, markers of ER‐stress, AMPK activity, adenine nucleotides, circulating GDF15, and food intake were assessed. AICAR and R419 caused ER and energetic stress, increased GDF15 expression and secretion, and suppressed food intake. Direct activation of AMPK β1 containing complexes by A769662 increased hepatic Gdf15 expression, circulating GDF15, and suppressed food intake, independent of ER stress. The effects of AICAR, R419, and A769662 on GDF15 were attenuated in AMPKβ1−/− mice. AICAR and A769662 increased GDF15 to a similar extent in WT and CHOP−/− mice. Herein, we provide evidence that AMPK plays a role in mediating the induction of GDF15 under conditions of energetic stress in mouse liver in vivo.

Chrono-communication and cardiometabolic health: The intrinsic relationship and therapeutic nutritional promises

“…In mouse models of ischaemia–reperfusion injury, GDF15 deficiency correlated with a major damage and cardiomyocyte apoptosis, while treatment with GDF15 counteracts ischaemia–reperfusion injury ( 177 – 179 ). This positive action of GDF15 treatment in obese and in ischemia-reperfused mice suggest that high levels of GDF15 play a compensatory role as recently suggested by Townsend et al., who demonstrated that the increase in hepatic GDF15 is associated with the energy stress response controlled by AMPK ( 180 ). Additionally, Patel et al.…”

Identification of endoplasmic reticulum stress-related biomarkers of diabetes nephropathy based on bioinformatics and machine learning

“…Also reported is the pathophysiological function of GDF15 in regulating ER stress. Through UPR signaling, ER stress promotes GDF15 expression and release [59]. Moreover, ablation of GDF15 lowers ER stress-induced β-cell apoptosis in diabetes [60].…”

Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese

“…Although GDF-15 is expressed in various tissues, its role as an adipokine that regulates metabolism, which overlaps with the functions of adiponectin, has attracted increasing attention. In addition, GDF-15 and adiponectin can improve IR via the activation of adenosine monophosphate-activated protein kinase (AMPK), a cellular energy sensor, in the liver and skeletal muscles, respectively ( 37 , 38 ). The G/A ratio is a recently proposed index whose increment was independently correlated with the risk of T2DM in all study populations aged 18–70 years and subgroups, compared to GDF-15 or adiponectin levels alone after adjusting for confounders; however, adiponectin concentrations had a stronger association with T2DM in relatively healthy men, but not in relatively healthy women and participants with metabolic disorders ( 17 ).…”